Clinical Trials Logo

Clinical Trial Summary

Prospective, non-interventional, multi-center study. Each subject will be followed for up to twelve months during the treatment with oral hormonal contraceptives(Qlaira ® or a Progestin Only Pill). For each subject demographic data and medical history will be documented at Visit 1: (Baseline). Bleeding profile, subjective assessment of study treatment (satisfaction and wellbeing) and adverse events including unintended pregnancies will be documented at Visit 2 (Month 3-5) and Visit 3 (Month 6-12). Data audit/monitoring will be done.


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01200186
Study type Observational
Source Bayer
Contact
Status Completed
Phase Phase 4
Start date October 2010
Completion date October 2014

See also
  Status Clinical Trial Phase
Completed NCT00567164 - Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ Phase 3
Completed NCT00480532 - A Study of Continuous Oral Contraceptives and Doxycycline N/A
Completed NCT00673686 - Study to Investigate the Effect of Missed Pills on Follicular Development in Two Application Regimens of SH T 00186 D Phase 2
Completed NCT00677703 - Txt Now 2 Decrease Pregnancies L8r: A Study to Evaluate the Effect of Daily Text Message Reminders on Pill Continuation N/A
Recruiting NCT06124274 - Oral Contraceptive vs Menstrual Cycle Ex Vivo Model N/A
Completed NCT00709644 - Bioequivalence Study of the Oral Contraceptive (OC) Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women. Phase 1